Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.3 USD | -0.20% | +7.71% | -1.91% |
12:23pm | North American Morning Briefing : Investors Brace -2- | DJ |
25/03 | Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam | MT |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.